Oxford BioMedica plc (OXB.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:44PM BST
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 203.00M |
| Enterprise value | 186.69M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.64 |
| Price/book (mrq) | 1.18 |
| Enterprise value/revenue | 1.57 |
| Enterprise value/EBITDA | -5.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.03 |
| 52-week change 3 | -54.14% |
| S&P500 52-week change 3 | 20.07% |
| 52-week high 3 | 474.50 |
| 52-week low 3 | 164.29 |
| 50-day moving average 3 | 189.31 |
| 200-day moving average 3 | 244.32 |
Share statistics
| Avg vol (3-month) 3 | 297.64k |
| Avg vol (10-day) 3 | 215.05k |
| Shares outstanding 5 | 100M |
| Implied shares outstanding 6 | 100.99M |
| Float 8 | 64.07M |
| % held by insiders 1 | 16.18% |
| % held by institutions 1 | 58.08% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:50 |
| Last split date 3 | 30 May 2018 |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | -51.78% |
| Operating margin (ttm) | -118.97% |
Management effectiveness
| Return on assets (ttm) | -12.05% |
| Return on equity (ttm) | -30.64% |
Income statement
| Revenue (ttm) | 119.02M |
| Revenue per share (ttm) | 1.24 |
| Quarterly revenue growth (yoy) | -32.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -64.85M |
| Net income avi to common (ttm) | -61.63M |
| Diluted EPS (ttm) | -0.64 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 129.43M |
| Total cash per share (mrq) | 1.34 |
| Total debt (mrq) | 113.15M |
| Total debt/equity (mrq) | 57.10% |
| Current ratio (mrq) | 3.32 |
| Book value per share (mrq) | 1.78 |
Cash flow statement
| Operating cash flow (ttm) | 6.48M |
| Levered free cash flow (ttm) | 10.69M |
© 2024 Yahoo. All rights reserved.